GVR Report cover Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Report

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics), By Phase (Phase I, II, III), By Region (APAC, North America), And Segment Forecasts, 2021 - 2028

  • Published Date: Sep, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68039-533-5
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 110

Report Overview

The global clinical trial equipment & ancillary solutions market size was valued at USD 2.3 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2021 to 2028. The global market will notice critical growth on account of the rising R&D investments, evolving need for clinical trials, and the rapid growth of the pharmaceutical and medical industries. The COVID-19 outbreak has slowed down the process of clinical trials. As a result of the pandemic, the market is shifting toward a decentralized approach to conducting clinical trials to achieve a high patient retention rate. The pandemic has affected the industry supply chain, resulting in a lack of clinical trial equipment & auxiliary supplies.

U.S. clinical trial equipment & ancillary solutions market size, by product, 2018 - 2028 (USD Million)

Lockdowns have also created logistical difficulties in transporting ancillary goods to various regions of the world. Due to the massive rise in the number of clinical studies being undertaken during the pandemic, the product demand has increased. As clinical trials evolve, more resources are required for a clinical trial, including the drugs, equipment, and ancillary supplies. Ancillary supplies include all items necessary to perform a clinical study, such as syringes, surgical knives, swabs, gloves, and any other material that the patient and medical professional need to administer the medication and analyze the effectiveness and safety parameters under examination.

Sourcing equipment & ancillary materials for clinical trials involves considerably more than just procurement. It needs an in-depth understanding of the study’s design and requirements, as well as rigorous proactive planning to guarantee that the most relevant equipment and supplies are bought at the correct time and at a reasonable price. A combination of internal knowledge and external help is strongly recommended to handle the complexity of equipment and ancillary supply, restocking, logistics, and expiry management. In an ideal world, research managers and project managers would be free to focus on the clinical trial’s execution while an expert partner handled the complexities of equipment & ancillary supplies as well as logistics.

Product Insights

On the basis of product, the market is divided into sourcing, supply/logistics, service, and others. The supply/logistics segment dominated the market and accounted for the largest revenue share of more than 38% in 2020. As clinical trials have become more global and diverse, they require a proper cold chain logistics system to maintain the integrity of temperature-sensitive drugs.

Due to the increasing complexity of clinical trials, the quantity of equipment and ancillary supplies required, as well as the number of diverse suppliers required to supply them, has increased substantially. The challenge of ensuring that supplies reach sites in a cost-effective manner for worldwide research has increased. With sourcing and distribution expertise, there is a single point-of-contact to supply and transport equipment and ancillary supplies all over the world. This streamlined and coordinated procedure removes the strain on both clinical trial teams and facilities.

Phase Insights

On the basis of phase, the global market has been sub-segmented into phases I, II, III, and IV. The phase III segment accounted for the maximum revenue share of the global market of more than 53% in 2020. The segment is likely to remain dominant even during the forecast years. Clinical studies in phase III are more complicated than those in earlier stages. Despite the fact that the number of medicines in this phase is relatively minimal, the complications associated with this phase are the largest.

In addition, the failure rate is also highest in this phase as the sample size and research design need precise dosing at an optimal level.The failure causes both human and financial damage, and most failures are caused by non-compliance with safety requirements. Such a scenario is likely to increase the demand for effective supply chain and logistics, which is projected to boost market growth over the coming years.

Regional Insights

North America dominated the global market in 2020 with the largest revenue share of over 41%. This is attributed to the fact that most of the pharmaceutical businesses are located in the U.S. and perform most of their business in this region. Favorable regulatory policies, the introduction of technologically advanced products by the market players, and increasing investments by pharmaceutical firms are expected to drive the regional market growth over the forecast period.

Global clinical trial equipment & ancillary solutions market share, by region, 2020 (%)

Asia Pacific is projected to be the fastest-growing regional market with a CAGR of more than 9% over the forecast period. The Asia Pacific region has become a hotspot for conducting clinical trials on account of the ease of regulatory compliance, cheap study costs, a growing patient population, and the existence of a few elite clinical institutions functioning as sites.

Key Companies and Market Share Insights

Various strategies, such as mergers, acquisitions, and collaborations, are adopted by key players to maintain their market share. For instance, in July 2021, Parexel, a prominent worldwide clinical research company, announced the signing of a final merger agreement, under which it would be purchased from Pamplona Capital Management for $8.5 billion by the EQT IX fund and the venture capital division under Goldman Sachs Management. Some prominent players in the global clinical trial equipment & ancillary solutions market include:

  • Ancillare, LP

  • Imperial Clinical Research Services

  • Woodley Equipment Company Ltd.

  • Thermo Fisher Scientific, Inc.

  • PPD, Inc.

  • PAREXEL International Corp.

  • MediCapital Rent

  • Quipment SAS

  • IRM

  • Marken

  • Myonex

  • Yourway 

Clinical Trial Equipment & Ancillary Solutions Market Report Scope

Report Attribute


Market Size value in 2021

USD 2.5 billion

Revenue forecast in 2028

USD 4.4 billion

Growth rate

CAGR of 8.2% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, phase, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; India; Japan; China; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Ancillare LP; Imperial Clinical Research Services; Woodley Equipment Company Ltd.; Thermo Fisher Scientific, Inc.; PPD, Inc.; PAREXEL International Corp.; MediCapital Rent; Quipment SAS; IRM; Marken; Myonex; Yourway

customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global clinical trial equipment & ancillary solutions market report on the basis of product, phase, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Sourcing

      • Procurement

      • Rental

    • Supply/Logistics

      • Transportation

      • Packaging

      • Others

    • Service

      • Calibrations

      • Equipment Servicing

      • Others

    • Others

  • Phase Outlook (Revenue, USD Million, 2016 - 2028)

    • Phase I

    • Phase II

    • Phase III

    • Phase IV

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • India

      • Japan

      • China

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.